Mourne Training Services Online Pharmaceutical Analysis Training

Mourne Training Services (MTS) is a training consultancy specialising in learning and development relating to the chemical analysis of pharmaceuticals. Our training solutions are designed to enable the learner to apply their new skills in the laboratory straight away. Additionally, they are designed to utilise the best features of e-learning and online learning technologies. MTS’s range of training solutions includes:

  • e-learning training courses, available in a distance learning format (iLearn) and as pre-prepared training courses for in-house use (UTrain)
  • Training courses delivered by MTS either as on-site training or using live, web-based training
  • Expert advice on your in-house training programmes
  • A wide range of supporting training resources

e-learning HPLC training courses

MTS offers e-learning, which is suitable for both individuals and groups. The distance learning option, iLearn, is an open enrolment HPLC training course that is delivered via the internet where the learner has access to the required training materials on specific dates.

The UTrain option consists of pre-prepared training courses, which can be delivered in-house. There are a number of available formats, including web-based training and interactive e-learning modules on CD-ROM.

e-learning solutions from MTS consist of three key elements:

  1. Training videos – these are animated lectures used to provide all the necessary information for the topic of training
  2. Exercises – so that learners can apply their new knowledge and skills (solutions for the exercises are provided)
  3. Assessment – a training certificate is awarded on satisfactory completion of an assessment

All three elements are accessed online via e-MTS, a virtual environment for learning.

HPLC troubleshooting training and HPLC method development training

MTS offers a range of training courses in pharmaceutical analysis. These may be delivered by MTS at your site, or alternatively via live, web-based training. Currently available training courses include:

  • Introduction to HPLC
  • Troubleshooting HPLC
  • HPLC analytical method development
  • Analytical method validation

Pharmaceutical analysis training consultancy services

MTS will work with you to develop effective training solutions for your organisation. We understand the challenges of setting up and implementing training programmes for complex analytical instrumentation. MTS services include:

  • Identifying staff training needs
  • Designing suitable training courses, or supporting your subject matter expert in this task
  • Delivering required training, or helping you to deliver the training, in an engaging and effective way
  • Evaluating how well your training programmes are working

Training relating to the chemical analysis of pharmaceuticals

The MTS training consultant is Oona McPolin BSc, MSc, CSci, CChem, MRSC. Prior to setting up MTS Oona gained over ten years’ experience working as an analytical chemist in the pharmaceutical industry. Additionally, Oona is an award-winning trainer with specialist knowledge in training design and the implementation of learning technologies. She also works as a part-time science lecturer and is the author of two books on the topics of HPLC and analytical method validation, which are available to purchase on the MTS website.

Make an enquiry

Follow this company

Follow the company to be always up to date with this company

Press Release

Exclusive Cooperation Between ARTES and the Ukrainian National Academy of Sciences

ARTES has announced that it has signed an exclusive marketing agreement with the Institute of Cell Biology of the National Academy of Science of Ukraine. The agreement is that the NAS technology based on the yeast organism Hansenula polymorpha is now exclusively marketed and licensed by ARTES Bio

Mourne Training Services Images

Products and Services


White Papers

Press Release

8 March 2011

Fujifilm Corporation and Merck, known as MSD outside the US and Canada, have announced that they have entered into a definitive agreement by which Fujifilm will acquire the Merck BioManufacturing Network, a leading provider of contract manufacturing and development services for the biopharmaceut

Read more
28 April 2010

Q Chip and ARTES Biotechnology have announced that they have signed a collaborative agreement to explore the co-development of a new sustained release formulation of interferon alpha 2a for the treatment of chronic hepatitis B and C. The study is designed to evaluate Q Chips' Q-Sphera&

Read more
16 November 2009

ARTES Biotechnology, specialised in recombinant protein production and process development from yeast expression systems, and Rhein Minapharm Biogenetics, a subsidiary of Minapharm SAE, jointly announced the successful production of a new target of a therapeutic protein. This was the first result

Read more
1 September 2009

ARTES Biotechnology has announced its collaboration with five other collaboration partners in a joint 28-month research programme that is granted by the national Deutsche Stiftung Umwelt within the ChemBioTec initiative. The Deutsche Bundesstiftung Umwelt DBU is one of Europe's largest foundation

Read more
5 August 2009

ARTES has announced that it has signed an exclusive marketing agreement with the Institute of Cell Biology of the National Academy of Science of Ukraine. The agreement is that the NAS technology based on the yeast organism Hansenula polymorpha is now exclusively marketed and licensed by ARTES Bio

Read more
10 May 2009

ARTES Biotechnology has announced its collaboration with Henkel in a joint three-year research programme that is granted by the German national BMBF (German Ministery of Education and Research) within the CLIB2021 cluster (Wettbewerb Industrielle Biotechnologie 2021). The cooperation aims to adva

Read more
14 January 2008

ARTES Biotechnology, which specializes in recombinant protein production from yeast expression systems, and Rhein Minapharm Biogenetics, a subsidiary of Minapharm, jointly announced the start of a strategic collaboration to develop three therapeutic proteins. Financial details were not disclosed.

Read more
8 October 2007

ARTES Biotechnology GmbH expands technology platform Having achieved notable success with the Hansenula technology for years, the biotech company ARTES has now concluded an exclusive partnership with the internationally renowned Leibniz Institute of Plant Genetics and Crop Plant

Read more
17 July 2007

"We are looking forward to working with an international team“, says Dr Melanie Dröttboom, head of business development of Artes Biotechnology GmbH. Biotech company Artes, based near Düsseldorf, has been confirmed that it is developing an aptamer-based microarray for

Read more
29 May 2007

ACE Pharmaceuticals today announced that the first patient has entered the Phase III trial also known as the Levamisole trial. This trial was accepted by the EMEA by November 2006. The goal of this trial, which was accepted by the EMEA in November 2006, is to assess the efficacy and sa

Read more
9 January 2007

ARTES announces the grant of the European patent on increasing recombinant protein secretion in yeast by co-expression of Calnexin, a protein responsible in intracellular quality control and sorting. In extensive studies, ARTES could show that overexpression of Calnexin results in sign

Read more
19 June 2006

Kiel - Erkrath, June 19, 2006. PROTEO Biotech AG, a wholly owned subsidiary of PROTEO Inc., USA, has signed a cooperation agreement with ARTES Biotechnology GmbH. The aim of the agreement is the marketing of Elafin, the lead product of PROTEO Biotech AG / PROTEO Inc., in India, Egypt and Argentin

Read more

Contact company

I have read and accept the terms and conditions and privacy policy.
We'd like to keep you informed about relevant promotions, products and services, if you would like not to receive these, check this box.
If you would like to hear from carefully selected third party companies, check this box
Follow this company to receive notifications when they update.